NOT-OD-24-153: Notice of ORWH's Participation in PA-24-245 "PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)"

Notice of ORWH's Participation in PA-24-245 "PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)"

Notice Number:

NOT-OD-24-153

Key Dates

Release Date:

July 19, 2024

Related Announcements

July 3, 2024 - PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed). See NOFO PA-24-245.

Issued by

Office of Research on Women's Health (ORWH)

Purpose

This Notice informs potential applicants that the NIH Office of Research on Women’s Health (ORWH) is participating, effective July 19, 2024, in the Notice of Funding Opportunity Announcement (NOFO) PA-24-245, “PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)”.

Inquiries

Please direct all inquiries to:

Elizabeth Anne Barr, Ph.D.
Office of Research on Women’s Health (ORWH)
Telephone: 301-402-7895
Email: elizabeth.barr@nih.gov